Objectives:

  • Risk factors for early mortality in sickle cell disease
  • Myeloablative and Non-Myeloablative preparative regimens in BMT for SCD
  • Access to BMT and strategies to increase the number of SCD patients cured
Session date: 
01/11/2018 - 5:00pm to 6:00pm CST
Location: 
UCMC
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Damiano Rondelli, MD